Tecan And Pierce Biotechnology, Inc. Collaborate To Develop And Co-Market Solutions For Drug Discovery
10/19/2005 5:11:18 PM
Tecan, a leader in the healthcare supply industry, and Pierce Biotechnology, a leading provider of advanced reagents for drug-discovery research, today announced an agreement to develop and co-market a series of high-throughput screening (HTS) solutions offering fluorescence lifetime technology (FLT).
comments powered by